keynote 630 pembrolizumab Options
This stops the activation from the T-cell which Typically would target and destroy cancer. The cancer cells can then multiply and unfold. When Keytruda binds to your PD-one receptor it helps prevent cancer cells from linking to and inactivating T-cells, permitting T-cell re-activation, and boosting the immune system's response against cancer. This